Biosimilars offer one of the clearest opportunities to lower costs and improve access,” says Maisha Draves, MD, MPH.
The treatment goal should drive our choice of technology, rather than the technology driving the treatment,” says Allan Tsung ...
What can I do to keep my daughter from losing her mother to cancer as I lost mine?” A friend asked that question after her ...
Nilay S. Shah, MD, MPH, discusses new data supporting selective use of CAC for those with borderline-to-intermediate risk.
A meta-analysis that compared orforglipron doses supports titrating to the 36-mg maintenance dose for patients with obesity.
More than three‑quarters of patients with critical illness experienced at least moderate pain during their ICU stay, according to findings from a prospective cohort study published in Acta ...
Candida infections are uncommon but often severe during secukinumab treatment, underscoring the need for early monitoring and ongoing pharmacovigilance, according to a pharmacovigilance study ...
Safety evidence deserves particular scrutiny when adult data are applied to children,” says Christina Sheil, MD.
FM‑OB physicians remain indispensable to rural maternity care. Equivalent outcomes would be an interesting academic finding if these physicians practiced everywhere. What makes FM‑OB physicians ...
Raman Gokal, MD, MBChB, discusses how negative beliefs and emotional states may contribute to chronic disease.
Yvette C. Terrie, RPh, BS Pharm, discusses striking the right balance between AI and human interaction in healthcare.
Regulatory restrictions are deterring US physicians in solo and independent practices from charging less for cash payments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results